Accessibility Menu
DaVita Stock Quote

DaVita (NYSE: DVA)

$129.08
(0.5%)
+0.67
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$129.08
Daily Change
(0.5%) +$0.67
Day's Range
$128.16 - $130.25
Previous Close
$129.08
Open
$128.45
Beta
0.52
Volume
606,933
Average Volume
782,168
Market Cap
9.2B
Market Cap / Employee
$129.08M
52wk Range
$122.93 - $179.6
Revenue
-
Gross Margin
0.27%
Dividend Yield
N/A
EPS
$10.18
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

DaVita Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
DVA-20.89%+41.77%+7.23%+3,068%
S&P+14.5%+93.32%+14.09%+1,052%

DaVita Company Info

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$3.38B6.1%
Gross Profit$943.28M8.6%
Gross Margin27.91%0.6%
Market Cap$10.75B-11.5%
Market Cap / Employee$0.14M0.0%
Employees76K8.6%
Net Income$275.22M-8.2%
EBITDA$705.18M4.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$796.96M58.4%
Accounts Receivable$2.44B6.0%
Inventory146.315.4%

Liabilities

Q2 2025YOY Change
Long Term Debt$12.20B13.7%
Short Term Debt$611.69M-35.1%

Ratios

Q2 2025YOY Change
Return On Assets4.85%-0.2%
Return On Invested Capital6.64%0.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$203.30M-70.0%
Operating Free Cash Flow$324.39M-59.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings17.6713.9215.1414.00-5.08%
Price to Book23.2731.95101.71-41.21-414.03%
Price to Sales1.110.980.960.84-14.92%
Price to Tangible Book Value-2.18-1.76-1.65-1.40-25.30%
Price to Free Cash Flow TTM9.888.517.058.54-11.37%
Enterprise Value to EBITDA37.4839.1742.7735.35-5.34%
Free Cash Flow Yield10.1%11.7%14.2%11.7%12.83%
Return on Equity104.4%159.1%260.9%635.3%509.84%
Total Debt$12.20B$12.07B$12.32B$12.82B9.76%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.